Top 50 Life Science Angel Investors (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
13 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Sahin Boydas
Angel
|
9 | United States, Canada, Mexico | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $500k–$150M |
|
Milad Alucozai
Angel
|
7 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $113k–$60M |
|
Jeffrey Dean
Angel
|
5 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Information Technology | $500k–$60M |
|
Nadav Rosenberg
Angel
|
5 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Software, Biotechnology, Artificial Intelligence | $1.1M–$21M |
|
Edward Lando
Angel
|
4 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, FinTech, Artificial Intelligence | $125k–$31M |
|
Kevin Moore
Angel
|
4 | United States, India, Canada | Seed, Pre-Seed, Angel | Software, Health Care, E-Commerce | $190k–$4M |
|
Elad Gil
Angel
|
4 | United States, United Kingdom, Israel | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $2M–$117M |
|
bumpkins profile
Angel
|
4 | United States, Canada, India | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $500k–$57M |
|
Christopher Gibson
Angel
|
4 | United States, United Kingdom, France | Series A, Seed, Series B | Biotechnology, Health Care, Pharmaceutical | $1.5M–$55M |
|
Jude Gomila
Angel
|
4 | United States, United Kingdom, India | Seed, Pre-Seed, Angel | Software, Information Technology, Artificial Intelligence | $70k–$4.7M |
|
Balaji Srinivasan
Angel
|
4 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Software | $650k–$28M |
|
Sam Altman
Angel
|
4 | United States, Canada, Ghana | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.2M–$100M |
|
Stefano Bernardi
Angel
|
3 | Italy, United Kingdom, Canada | Seed, Pre-Seed | Blockchain, Software, Biotechnology | $100k–$18M |
|
Andrew Keys
Angel
|
3 | United States, India, Norway | Seed, Pre-Seed, Series A | Software, Finance, Blockchain | $1M–$34M |
|
Ian Hogarth
Angel
|
3 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, E-Commerce | $668k–$28M |
|
Andrew Nutter
Angel
|
3 | France, United Kingdom, United States | Seed, Pre-Seed, Venture - Series Unknown | Software, SaaS, FinTech | $550k–$4.9M |
|
Kevin Mahaffey
Angel
|
3 | United States, Canada, Israel | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $700k–$30M |
|
Erik Peterson
Angel
|
3 | United States, Canada, Algeria | Seed, Equity Crowdfunding, Series A | Software, SaaS, Mobile | $69k–$20M |
|
Bradley Horowitz
Angel
|
3 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $150k–$36M |
|
Annie Vereecken
Angel
|
3 | Belgium | Seed, Series A, Venture - Series Unknown | Medical, Biotechnology, Hospital | $2M–$30M |
|
Paul Forster
Angel
|
3 | United Kingdom, Germany, United States | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $1M–$26M |
|
Jeff Hammerbacher
Angel
|
3 | United States, Germany | Seed, Series A, Angel | Artificial Intelligence, Software, Biotechnology | $330k–$25M |
|
Albert Wenger
Angel
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Software, Internet, Analytics | $650k–$30M |
|
Chris Gibson
Angel
|
3 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Esther Dyson
Angel
|
3 | United States, Egypt, Canada | Seed, Series A, Angel | Health Care, Software, Artificial Intelligence | $300k–$16M |
|
Darian Shirazi
Angel
|
3 | United States, Germany, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $2M–$73M |
|
Mei Z.
Angel
|
3 | United States, United Kingdom, Singapore | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $1M–$156M |
|
Darrin Disley
Angel
|
2 | United Kingdom | Seed, Series A | Biotechnology, Health Care, Big Data | |
|
Alec Nielsen
Angel
|
2 | United States | Seed | Biotechnology, Robotics, Biopharma | |
|
Joshua Elkington
Angel
|
2 | United States | Seed | Biopharma, Life Science, Biotechnology | $2.6M–$2.6M |
|
Ankit Jain
Angel
|
2 | United States | Seed, Pre-Seed | Health Care, Medical, Hospital | |
|
John Ballantyne
Angel
|
2 | United States, Singapore | Seed, Series A, Angel | Health Care, Biotechnology, Therapeutics | $4.5M–$30M |
|
CJ Reim
Angel
|
2 | United States | Series A, Seed, Series D | SaaS, Robotics, E-Commerce | $3.7M–$150M |
|
Ed Parkinson
Angel
|
2 | United Kingdom | Seed | Health Care, Life Science, Biotechnology | $1.9M–$3M |
|
Robert Kopple
Angel
|
2 | United States, United Kingdom | Convertible Note, Venture - Series Unknown | FinTech, Finance, Life Science | $3.3M–$4.8M |
|
Damien Lane
Angel
|
2 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Series A | Software, SaaS, Health Care | $459k–$16M |
|
Ruchi Sanghvi
Angel
|
2 | United States, India, China | Seed, Series A, Series C | Software, Artificial Intelligence, Information Technology | $600k–$80M |
|
Craig Mundie
Angel
|
2 | United States | Seed, Series B, Series C | Life Science, Chemical, Genetics | |
|
Ryan Bethencourt
Angel
|
2 | United States, Chile, India | Pre-Seed, Seed, Angel | Biotechnology, Food Processing, Food and Beverage | $100k–$4.6M |
|
Avichal Garg
Angel
|
2 | United States, Canada, Mexico | Seed, Series A | Software, Blockchain, Internet | |
|
Jan Hammer
Angel
|
2 | China, United States, Czech Republic | Series A, Series B, Seed | Health Care, Medical, Medical Device | |
|
Nicholas Edwards
Angel
|
2 | United Kingdom | Seed | Medical, Health Care, Life Science | |
|
Luc Vauterin
Angel
|
2 | Belgium | Seed, Series A | Life Science, Data Integration, Data Visualization | |
|
Sauli Törmälä
Angel
|
2 | Finland | Seed | Life Science, Biotechnology | $584k–$1.3M |
|
Pierre Drion
Angel
|
2 | Belgium | Series A, Series B | Biotechnology, Health Care, Life Science | |
|
Holger Hübner
Angel
|
2 | Germany | Seed, Pre-Seed | B2B, SaaS, Audio | $177k–$987k |
|
Peter Harris
Angel
|
2 | United States | Seed | Life Science, Biotechnology, Health Diagnostics | $2.4M–$5M |
|
Leena Niemistö
Angel
|
2 | Finland, United States | Seed, Pre-Seed | Health Care, Software, E-Commerce | $480k–$3.2M |
|
Thor Bjorgolfsson
Angel
|
2 | United Kingdom, Germany | Seed, Series A, Series C | Big Data, TV, TV Production | |
| Access all 840 angel investors in Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Sahin Boydas is the Founder & CEO of Lovie.co. He is part of PEF Community as PEF Chapter Lead.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 290
- Round size: Seed $500k–$15M; Series A $8M–$36M; Series B $23M–$150M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lamb Labs — Lamb Labs is building model processing units that hardcode AI models into silicon for faster, more efficient inference.
- Normal Computing — Normal Computing was founded by former members of the Google Brain Team, Palantir, and X who unlocked AI for some of the largest-scale and most mission-critical production systems, and the industry leading ML frameworks for Probabilistic and Quantum AI.
- Reliable Robotics — Advanced automation will make aircraft safer, more available, more affordable and fundamentally transformative to the way goods and people move around the planet.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $1M–$7M; Pre-Seed $113k–$5M; Series A $13M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Jeff Dean is the Co-founder and CEO of DiscoveryLoop. He previously worked at Google as Chief Scientist at Google DeepMind and Google Research. Jeff attended the University of Washington, where he earned a PhD in Computer Science.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 111
- Round size: Seed $2.5M–$34M; Pre-Seed $500k–$3M; Series A $10M–$60M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- G5 Labs — G5 is the semantic abstraction layer that makes AI-native software development compilable, mergeable, and governable for enterprises.
- Phinity Labs — Phinity Labs builds AI systems designed to fully automate the entire silicon microchip engineering process, spanning from original architectural concepts to final manufacturing preparation.
- Volantis — Volantis specializes in developing AI-driven semiconductor solutions. The company focuses on creating advanced systems that support high-performance computing for various applications, including networking, data centers, and edge computing. Volantis provides integrated hardware and software platforms designed to optimize processing power, energyefficiency, and scalability. Their technology aims to enhance the capabilities of existing infrastructure, making it adaptable to emerging computational demands. The company's solutions cater to industries that require robust, efficient computing power at scale.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 16
- Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 581
- Round size: Seed $950k–$6.3M; Pre-Seed $125k–$3.3M; Series A $5M–$31M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Humera — Humera - AI CAPTCHA That Knows You're Human
- Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
- Heywa Labs — Two products, one engine. Heywa Studio for businesses, Heywa for anyone with a question worth following.
Kevin Moore has 15 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, India, Canada
Investor stats
- Total investments: 105
- Round size: Seed $190k–$4M; Pre-Seed $800k–$2.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Trace — AI orchestration layer for modern teams
- Augmend — Create documentation and an AI assistant from any video.
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 263
- Round size: Seed $2M–$17M; Series A $9.5M–$50M; Series B $27M–$117M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- NavigateAI — An AI copilot for every person in the field. NavigateAI upskills and coaches your team, runs real-time quality control, manages the project in the background, and provides expert knowledge, instantly.
- Harvey — Harvey is an artificial intelligence technology service provider.
- Cognition — Cognition develops artificial intelligence systems for software engineering and code automation. The company operates Devin, an AI software engineer that plans, writes, tests, debugs, and deploys code through integrated development workflows. Its platform works with existing development tools and codebases to support engineering tasks acrossapplication development, maintenance, and issue resolution. Cognition also provides tools that assist teams with system design, technical workflows, and collaborative coding processes. The company focuses on AI agents that automate repetitive engineering work while supporting software teams in managing complex development tasks.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 49
- Round size: Seed $2.3M–$9.1M; Pre-Seed $500k–$2M; Series A $6.8M–$57M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 28
- Round size: Seed $1.5M–$14M; Series A $10M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Zanskar — Zanskar combines field geology, artificial intelligence, and computational geoscience to discover geothermal resources and develop clean, firm power.
- Play Health — Play Health is no longer available. The team behind it is now building Paceline Bio.
- Dunia Innovation — Catalysing the energy transition.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 67
- Round size: Seed $1.4M–$4.7M; Angel $70k–$1.3M; Pre-Seed $1M–$2.9M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Clara — Primary care, supported by AI, that never closes, never rushes you, and never forgets the details.
- Dirac Labs — Universal Navigation powered by Quantum Sensing & AI
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Balaji Srinivasan is based out of Singapore, Central Region and is the Founder, Investor, and Author of Network School. Balaji previously worked at Coinbase as a CTO. Balaji Srinivasan attended Stanford University.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 276
- Round size: Seed $2.3M–$15M; Pre-Seed $650k–$4.2M; Series A $6M–$28M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
- Dirac Labs — Universal Navigation powered by Quantum Sensing & AI
- Physical Superintelligence — Physical Superintelligence develops physical superintelligence systems that use AI-driven research to study physics, engineer physical systems, and explore new physical laws. Its approach combines human scientists with virtual physicists that conduct autonomous research campaigns covering hypothesis development, verification, experimentation,engineering, and deployment. The company focuses initially on the physical infrastructure underlying AI, including energy, materials, computation, sensing, and manufacturing.
Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Ghana
Investor stats
- Total investments: 199
- Round size: Seed $1.2M–$9.3M; Series A $10M–$50M; Series B $17M–$100M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
- Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
- Red Queen Bio — Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine. But the same tools are also lowering the barrier for bad actors to engineer dangerous pathogens, and opening up an entirely new category of threats, including viruses designed to evade human immunity.Defense has to keep pace with offense.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Blockchain, Software, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Italy, United Kingdom, Canada
Investor stats
- Total investments: 18
- Round size: Seed $100k–$18M; Pre-Seed $874k–$2.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Freatic — Building the monetization layer for your alpha
- Niulinx — Politecnico di Milano spin-off building autonomous driving technology.
- Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Industry: Software, Finance, Blockchain
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 56
- Round size: Seed $1.5M–$7.9M; Pre-Seed $668k–$7.5M; Series A $11M–$28M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Cordless — Bridging the gap between voice and text
- Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 26
- Round size: Seed $550k–$4.9M; Pre-Seed $902k–$3.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 160
- Round size: Seed $1.4M–$8.2M; Pre-Seed $700k–$5.6M; Series A $5.3M–$30M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Cara — Cara AI helps insurance agencies, brokerages, and wholesalers automate sales and servicing workflows, reduce manual tasks, and focus on client relationships.
- Osmo Studio — Osmo is an AI-native video editor for product launch videos and motion graphics. Turn ideas, Figma files, and footage into polished, on-brand animations, built as editable code.
- Triangle Health — Triangle brings your medical records together, reads them with you in plain language and researches your options, with a physician-reviewed analysis.
Erik Peterson is the Founder at DormTrader.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Equity Crowdfunding, Series A
- Geography: United States, Canada, Algeria
Investor stats
- Total investments: 65
- Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 137
- Round size: Seed $150k–$18M; Pre-Seed $500k–$6.6M; Series A $7.5M–$36M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.
- Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Annie Vereecken
Show more...Investment focus
- Industry: Medical, Biotechnology, Hospital
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Seed $2M–$6M; Series A $9.2M–$30M; Venture - Series Unknown $4.1M–$8.8M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 83
- Round size: Seed $1M–$6.9M; Pre-Seed $1.1M–$3.5M; Series A $3.7M–$26M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Wassist — Launch your AI sales agent on WhatsApp for Shopify in under 60 seconds. Recover 30-50% of abandoned carts and increase conversions by 3x.
- Capsa AI — Providing next-generation investors with a competitive edge.
- Applied Protein Labs — Applied Protein Labs is a biotech company based in the London, UK. The company specialises in the development of next-generation proteins for industry and agriculture.
Jeff Hammerbacher is based out of New York and is the Chairman and Co-Founder of Ortet. Jeff previously worked at New Mountain Capital as a Senior Advisor and Portfolio Company Board Member. Jeff Hammerbacher attended Harvard University.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: United States, Germany
Investor stats
- Total investments: 33
- Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lamin — Improve your workflows with open-source data access and long-term memory. Query, trace, and govern with a lineage-native, format-agnostic lakehouse for agents and teams. With support for biological formats and registries.
- Ridge AI — Ridge builds interactive dashboards and AI data agents you can embed in your product, so customers see the value you deliver. Start a free trial.
- United Manufacturing Hub — The United Manufacturing Hub is an Open-Source Industrial IoT Infrastructure Platform enabling to easily connect, configure, manage, and maintain their factory.
Albert Wenger is based out of New York, New York, and is the Director of Humane Genomics. Albert previously worked at goTenna as a Director. Albert Wenger attended Massachusetts Institute of Technology.
Show more...Investment focus
- Industry: Software, Internet, Analytics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 111
- Round size: Seed $650k–$16M; Series A $2.5M–$23M; Series B $4.3M–$30M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Brale — One regulated system for stablecoin issuance, custody, payments, and compliance. 75+ programs in production across 45 US jurisdictions. SOC 2 Type II. Book a demo.
- Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
- Phlair — 77NEKO merupakan acces situs utama untuk permainan viral yang tentunya paling kekinian dan bukan hanya itu dengan memanfaatkan fitur yang tersedia pemain dapat berpeluang cuan lebih besar dan menjadi sultan.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Esther Dyson - Founder @ Way to Wellville
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Series A, Angel
- Geography: United States, Egypt, Canada
Investor stats
- Total investments: 93
- Round size: Seed $300k–$4M; Angel $330k–$2.9M; Series A $1.5M–$16M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Darian Shirazi is the Managing Partner of Gradient.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 189
- Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $22M–$73M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- SolveAI —
- Rowspace — You built your firm's edge. Compound it with AI.
- Harmattan AI — Building the Future of Autonomous Warfare.
Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 32
- Round size: Seed $4M–$101M; Pre-Seed $1M–$11M; Series A $17M–$156M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FlyMy.AI — Real-time AI cloud
- Medra AI — Building robotics to accelerate scientific breakthroughs. At Medra, our mission is to automate repetitive wetlab tasks so scientists can more easily collect data and run the experiments needed to make groundbreaking scientific discoveries.
- Periodic Labs — From bits to atoms.
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Big Data
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Alec Nielsen is the Founder & CEO at Asimov.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Biopharma
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- LatchBio — The command center for all gene-editing bioinformatics. Analyze your CRISPR data without code in 5 minutes.
- Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
- Lamin — Lamin provides an open data platform for biology, enabling tracked data management, streamlined collaboration, and learning at scale.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Joshua Elkington
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.6M–$2.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
- Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more...Investment focus
- Industry: Health Care, Medical, Hospital
- Stage:Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Advex AI — Composer is a no-code AI vision system that enables industrial teams to train, deploy, and manage complex visual inspection tasks across manufacturing lines. Composer uses VLMs and synthetic data to achieve production performance in minutes.
- RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
- Empower Sleep — Empower Sleep provides personalized sleep care online
John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Angel
- Geography: United States, Singapore
Investor stats
- Total investments: 11
- Round size: Seed $4.5M–$7M; Series A $12M–$30M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- SmartWorx — AI-native platform for regulated, high-stakes environments. Purpose-built to solve the hardest integration and workflow problems where compliance isn't optional.
- GlucoTrack — We are pleased to announce that the diabetes technology business focused on developing our Continuous Blood Glucose Monitor (CBGM) platform will now operate
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more...Investment focus
- Industry: SaaS, Robotics, E-Commerce
- Stage:Series A, Seed, Series D
- Geography: United States
Investor stats
- Total investments: 18
- Round size: Seed $3.7M–$9.7M; Series A $5M–$27M; Series D $80M–$150M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Ed Parkinson
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Round size: Seed $1.9M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
Robert C. Kopple is based out of Vancouver, Ontario, and is the Partner of Kopple, Klinger & Elbaz. Robert previously worked at Gelum Resources as a Board of Directors. Robert C. Kopple attended New York University.
Show more...Investment focus
- Industry: FinTech, Finance, Life Science
- Stage:Convertible Note, Venture - Series Unknown
- Geography: United States, United Kingdom
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $3.3M–$4.8M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
- ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 39
- Round size: Seed $459k–$3.1M; Pre-Seed $660k–$1M; Series A $3.2M–$16M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Narchie — Create a home that's uniquely yours with Narchie. Shop sustainably, minimize waste, and find one-of-a-kind homeware items.
- Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
- Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
Ruchi Sanghvi is the Founder of South Park Commons.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series C
- Geography: United States, India, China
Investor stats
- Total investments: 66
- Round size: Seed $600k–$4.6M; Series A $3M–$23M; Series C $18M–$80M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Sundial — Stop writing pipelines and complex SQL. Go from raw data to entities, metrics, visualizations and answers in just a few clicks
- SCUBA Analytics — Unlock the power of data collaboration in experience-driven industries. Gain intelligence, measurement, and activation of audience opportunities with SCUBA's privacy-enabled insights.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Craig J. Mundie is based out of Seattle, Washington, and is the Owner of Mundie & Associates LLC. Craig previously worked at Microsoft as a Chief Research and Strategy Officer. Craig J. Mundie attended the Georgia Institute of Technology.
Show more...Investment focus
- Industry: Life Science, Chemical, Genetics
- Stage:Seed, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Stoicheia — NAGASPIN99 adalah link situs slot gacor hari ini yang menawarkan bonus berlimpah khusus pemain baru. Klik Daftar dan raih kemenangan besar bersama naga api sekarang juga.
- Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.
Show more...Investment focus
- Industry: Biotechnology, Food Processing, Food and Beverage
- Stage:Pre-Seed, Seed, Angel
- Geography: United States, Chile, India
Investor stats
- Total investments: 16
- Round size: Seed $100k–$4.6M; Pre-Seed $100k–$945k
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
- Sobo Foods — Sobo Foods is a plant based comfort food provider.
- Veggie Victory — VeggieVictory is Nigeria’s first plant-based food tech company bringing people a healthier and more sustainable lifestyle through plant-based meats and meals.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more...Investment focus
- Industry: Software, Blockchain, Internet
- Stage:Seed, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 85
- Lead/follow: no public data
Portfolio highlights
- Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Matic — The world's most advanced floor cleaner. Your home's best helper.
- Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States, Czech Republic
Investor stats
- Total investments: 64
- Lead/follow: no public data
Portfolio highlights
- Sofía — Improving the way millions of people take care of their health
- Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Luc Vauterin - Board Member @ ONTOFORCE
Show more...Investment focus
- Industry: Life Science, Data Integration, Data Visualization
- Stage:Seed, Series A
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Seed $584k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Pierre Drion - CEO @ Petercam
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: Belgium
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Holger Hübner
Show more...Investment focus
- Industry: B2B, SaaS, Audio
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 5
- Round size: Seed $560k–$987k; Pre-Seed $177k–$329k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Peter Harris
Show more...Investment focus
- Industry: Life Science, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.4M–$5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- CND Life Sciences — CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Leena Niemistö
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Pre-Seed
- Geography: Finland, United States
Investor stats
- Total investments: 19
- Round size: Seed $480k–$3.2M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Vapaus — A circular economy startup Vapaus provides sustainable mobility solutions – Employee benefit bicycles and shared electric vehicles as a ready-to-use serviceWith its services, Vapaus supports customers’ to create and strengthen a better experience of the work community, to save on the costs of commuting and business travels, and to move towardssmarter and more environmentally friendly modes of transport, both at work and in employees’ leisure time.Every kilometer traveled by the Vapaus mobility solution removes carbon dioxide from the air, helping not only the environment but also customers on their way to carbon neutrality. The mission of Vapaus is to be a global leader when it comes to sustainable Corporate Mobility.
- ADESANTE — SurgeryVision is a Virtual Reality solution for Surgeons. Product is intended to be used for planning surgical procedures.
- Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more...Investment focus
- Industry: Big Data, TV, TV Production
- Stage:Seed, Series A, Series C
- Geography: United Kingdom, Germany
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Olvin — Olvin helps reactive real-world businesses get ahead of the curve and become proactive through the use of its AI powered, predictive analytics platform. Harnessing billions of real world data points, from events and precise location, through to weather and points of interest, Olvin's advanced neural network identifies patterns. Through theuse of both probabilistic and deterministic scoring, Olvin's AI provides actionable insights to brands, retailers and businesses to give them an unparalleled opportunity to delight their customers, identify opportunities and get ahead of potential threats.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Life Science Angel investor funding at a glance
Stats across 574 deals from 840 investors.
Access all 840 angel investors in Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 840 angel investors investing in Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!